Examkin

Question

Difficulty: MediumOccupational and Environmental Exposures

A 32-year-old woman, G1P0, at 22 weeks gestation, presents to the clinic with gradually worsening shortness of breath and a persistent dry cough over the past 5 months. She works as a materials technician in a high-tech aerospace ceramics manufacturing facility. Her temperature is 37.1°C (98.8°F), blood pressure is 110/70 mmHg, pulse is 84/min, and respiratory rate is 18/min. Pulse oximetry shows 96% on room air. Physical examination reveals scattered fine crackles in both lung fields. A chest radiograph, performed with appropriate abdominal shielding, demonstrates bilateral hilar lymphadenopathy and reticular opacities. A subsequent transbronchial biopsy reveals noncaseating granulomas with no acid-fast bacilli or fungi. Which of the following is the most appropriate next step in management to establish the specific etiology of this patient's condition?

  1. Beryllium lymphocyte proliferation testAnswer
  2. B
    Reassurance that her symptoms and imaging findings represent normal physiologic adaptations to pregnancy
  3. C
    Empiric initiation of broad-spectrum antibiotics
  4. D
    Transthoracic echocardiography
  5. E
    Measurement of thyroid-stimulating hormone and free T4 levels

Answer

The most appropriate next step is a Beryllium lymphocyte proliferation test to confirm berylliosis.
This patient's presentation of progressive dyspnea, dry cough, bilateral hilar lymphadenopathy, and noncaseating granulomas is highly characteristic of chronic beryllium disease (berylliosis) given her occupational exposure. She works as a materials technician in aerospace ceramics, an industry with known beryllium exposure risks (along with the nuclear and electronics industries). Because berylliosis is clinically and histologically indistinguishable from sarcoidosis, the diagnosis must be confirmed by demonstrating specific beryllium sensitization. The beryllium lymphocyte proliferation test (BeLPT), performed on blood or bronchoalveolar lavage fluid, is the most appropriate next step to establish this etiology.

Step-by-Step Solution

1
Identify the primary clinical syndrome from the patient's history and diagnostics.
The patient has a chronic interstitial lung disease characterized by dyspnea, cough, bilateral hilar lymphadenopathy, and noncaseating granulomas.
Recognizing the syndrome narrows the differential diagnosis to granulomatous diseases such as sarcoidosis, berylliosis, or infectious etiologies (which are ruled out by negative stains).
2
Correlate the clinical syndrome with the patient's occupational history.
The patient works in an aerospace ceramics manufacturing facility, which is a classic exposure risk for beryllium.
Berylliosis is clinically and histologically indistinguishable from sarcoidosis; the occupational history is the key distinguishing factor.
3
Select the appropriate specific diagnostic test based on the suspected exposure.
The Beryllium lymphocyte proliferation test (BeLPT) is chosen.
BeLPT detects beryllium-specific T-cell sensitization and is the gold standard for differentiating chronic beryllium disease from sarcoidosis.

Key Concept

Berylliosis presents identically to sarcoidosis (dyspnea, hilar adenopathy, noncaseating granulomas) but is distinguished by an occupational exposure history in aerospace, electronics, or ceramics, and is confirmed using the beryllium lymphocyte proliferation test (BeLPT).
Estimated Time:1m 15s
Rate this question

Topics

Occupational and Environmental Exposures

More questions from this topic